HomeCompareGILD vs LOW

GILD vs LOW: Dividend Comparison 2026

GILD yields 2.34% · LOW yields 2.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LOW wins by $70.19M in total portfolio value
10 years
GILD
GILD
● Live price
2.34%
Share price
$136.34
Annual div
$3.19
5Y div CAGR
17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$1,614.90
Full GILD calculator →
LOW
LOW
● Live price
2.04%
Share price
$232.58
Annual div
$4.75
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70.22M
Annual income
$64,185,884.20
Full LOW calculator →

Portfolio growth — GILD vs LOW

📍 LOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGILDLOW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GILD + LOW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GILD pays
LOW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GILD
Annual income on $10K today (after 15% tax)
$198.88/yr
After 10yr DRIP, annual income (after tax)
$1,372.67/yr
LOW
Annual income on $10K today (after 15% tax)
$173.60/yr
After 10yr DRIP, annual income (after tax)
$54,558,001.57/yr
At 15% tax rate, LOW beats the other by $54,556,628.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GILD + LOW for your $10,000?

GILD: 50%LOW: 50%
100% LOW50/50100% GILD
Portfolio after 10yr
$35.13M
Annual income
$32,093,749.55/yr
Blended yield
91.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GILD right now

GILD
Analyst Ratings
37
Buy
20
Hold
1
Sell
Consensus: Buy
Price Target
$158.71
+16.4% upside vs current
Range: $105.00 — $180.00
Altman Z
4.1
Piotroski
8/9
LOW
Analyst Ratings
31
Buy
19
Hold
1
Sell
Consensus: Buy
Price Target
$288.25
+23.9% upside vs current
Range: $230.00 — $325.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GILD buys
0
LOW buys
0
No recent congressional trades found for GILD or LOW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGILDLOW
Forward yield2.34%2.04%
Annual dividend / share$3.19$4.75
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17.3%100%
Portfolio after 10y$29.1K$70.22M
Annual income after 10y$1,614.90$64,185,884.20
Total dividends collected$7.6K$69.74M
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$158.71$288.25

Year-by-year: GILD vs LOW ($10,000, DRIP)

YearGILD PortfolioGILD Income/yrLOW PortfolioLOW Income/yrGap
1← crossover$10,974$274.45$11,108$408.46$134.00LOW
2$12,073$330.19$12,734$848.11$661.00LOW
3$13,316$398.20$15,443$1,817.25$2.1KLOW
4$14,730$481.49$20,643$4,119.23$5.9KLOW
5$16,345$583.87$32,380$10,292.23$16.0KLOW
6$18,199$710.26$64,823$30,176.08$46.6KLOW
7$20,340$866.96$182,277$112,916.51$161.9KLOW
8$22,826$1,062.22$788,517$593,481.00$765.7KLOW
9$25,731$1,306.80$5,642,510$4,798,796.17$5.62MLOW
10$29,147$1,614.90$70,223,370$64,185,884.20$70.19MLOW

GILD vs LOW: Complete Analysis 2026

GILDHealthcare

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Full GILD Calculator →

LOWConsumer Discretionary

Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States and internationally. The company offers a line of products for construction, maintenance, repair, remodeling, and decorating. It provides home improvement products, such as appliances, seasonal and outdoor living, lawn and garden, lumber, kitchens and bath, tools, paint, millwork, hardware, flooring, rough plumbing, building materials, decor, lighting, and electrical. It also offers installation services through independent contractors in various product categories; extended protection plans; and in-warranty and out-of-warranty repair services. The company sells its national brand-name merchandise and private brand products to homeowners, renters, and professional customers. As of January 28, 2022, it operated 1,971 home improvement and hardware stores. The company also sells its products through websites comprising Lowes.com and Lowesforpros.com; and through mobile applications. Lowe's Companies, Inc. was founded in 1921 and is based in Mooresville, North Carolina.

Full LOW Calculator →
📬

Get this GILD vs LOW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GILD vs SCHDGILD vs JEPIGILD vs OGILD vs KOGILD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.